DT
AEGR

Diversified Trust’s Aegerion Pharmaceuticals AEGR Stock Holding History

Diversified Trust’s Portfolio AEGR Stock Details AEGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		$783K Sell
11,031
-450
-4% -$34.4K 0.08% 244
2013
Q3 		$984K Sell
11,481
-2,555
-18% -$217K 0.1% 206
2013
Q2 		$890K Buy
+14,036
New +$745K 0.11% 193

Other funds holding AEGR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Diversified Trust's AEGR Position: Q4 2013 in Review

Diversified Trust reduced its Aegerion Pharmaceuticals (AEGR) stake by 3.9% in Q4 2013, selling an estimated $34.4K and leaving 11,031 shares worth $783K. The position accounts for 0.08% of the portfolio, ranked #244.

Diversified Trust first reported a position in AEGR in Q2 2013 and has held it in 3 quarters since. The position peaked at $984K in Q3 2013. 150 funds tracked by Wall St. Rank hold AEGR as of Q4 2013.

  • Diversified Trust held 11,031 shares of Aegerion Pharmaceuticals worth $783K as of Q4 2013.
  • Diversified Trust sold 450 Aegerion Pharmaceuticals shares in Q4 2013, an estimated $34.4K.
  • Aegerion Pharmaceuticals made up 0.08% of Diversified Trust's portfolio in Q4 2013, its #244 holding.
  • Diversified Trust first reported a position in Aegerion Pharmaceuticals in Q2 2013 and has held it in 3 quarters since.
  • Diversified Trust's Aegerion Pharmaceuticals position peaked at $984K in Q3 2013.
  • 150 funds tracked by Wall St. Rank held Aegerion Pharmaceuticals as of Q4 2013.

Based on Diversified Trust's 13F filing for Q4 2013, filed 10 Feb 2014.